[1] 金艳丽. 氟喹诺酮类药物在结核病治疗中的研究进展[J]. 中国城乡企业卫生, 2021, 36(8):58-60. [2] 王璐璐, 刘慧. 2012-2014年南京地区常用喹诺酮类抗菌药利用分析[J]. 药物流行病学杂志, 2015, 24(12):736-739. [3] 薛茹, 曹兰芳. 喹诺酮类抗菌药物在儿童中的应用进展[J]. 儿科药学杂志, 2020, 26(3):62-65. [4] 张延霞, 张延红, 张增红, 等. 喹诺酮类及头孢类抗生素致某医院老年患者急性药物性肝损伤的因素分析[J]. 实用医药杂志, 2019, 36(10):909-911. [5] 杨鸿溢. 氟喹诺酮类药物致肝损伤真实世界大样本信息化主动监测与评价研究[D]. 重庆:重庆医科大学, 2020. [6] MARTINS M T, BARRETO F, HOFF R B, et al. Determination of quinolones and fluoroquinolones, tetracyclines and sulfonamides in bovine, swine and poultry liver using LC-MS/MS[J]. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 2015, 32(3):333-341. [7] FIGUEIRA-COELHO J, PEREIRA O, PICADO B, et al. Acute hepatitis associated with the use of levofloxacin[J]. Clin Ther, 2010, 32(10):1733-1737. [8] 杨金兰, 王升, 胡伟, 等. 喹诺酮类药物致肝毒性文献分析[J]. 中国药房, 2019, 30(2):244-249. [9] MERLE C S, FIELDING K, SOW O B, et al. A four-month gatifloxacin-containing regimen for treating tuberculosis[J]. N Engl J Med, 2014, 371(17):1588-1598. [10] 唐军, 刘平羽, 周鸣. 加替沙星56例不良反应分析[J]. 药物流行病学杂志, 2011, 20(1):30-31. [11] OLADAPO ROTIMI S, TEMITAYO OLUGBEMI I, ANUOLUWAPO ROTIMI O. Alterations of genes involved in apoptosis and epigenetic modulation associated with gatifloxacin-induced oxidative stress in rat liver[J]. Biomed Pharmacol J, 2018, 11(1):583-591. [12] STARK R, GRZELAK M, HADFIELD J. RNA sequencing:the teenage years[J]. Nat Rev Genet, 2019, 20(11):631-656. [13] SCHAAP F G, TRAUNER M, JANSEN P L. Bile acid receptors as targets for drug development[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(1):55-67. [14] URLEP Ž, LORBEK G, PERŠE M, et al. Disrupting hepatocyte Cyp51 from cholesterol synthesis leads to progressive liver injury in the developing mouse and decreases RORC signalling[J]. Sci Rep, 2017, 7:40775. |